Dynamic contrast-enhanced MRI quantification of synovium microcirculation in experimental arthritis

American Journal of Roentgenology

Volumn 186, Issue 4, 2006, Pages 1165-1171

  Doria, Andrea S ^a,b   Noseworthy, Michael ^b,c,d   Oakden, Wendy ^c   Moineddin, Rahim ^e   Rayner, Tammy ^a   Tassos, Vivian ^a   Engelberts, Doreen ^a   Pritzker, Kenneth ^f   Rogers, Marianne ^f   Jong, Roland ^f   Babyn, Paul ^a,b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Brain Body Institute   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Animal studies; Contrast media; Dynamic MRI; Musculoskeletal imaging; Pediatric imaging; Rabbit

Indexed keywords

AMYLOID A PROTEIN; CONTRAST MEDIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CAPILLARY LEAK SYNDROME; CAPILLARY PERMEABILITY; CLINICAL ASSESSMENT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE COURSE; HISTOPATHOLOGY; JUVENILE RHEUMATOID ARTHRITIS; LABORATORY DIAGNOSIS; MICROCIRCULATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RABBIT; SIGNAL NOISE RATIO; STATISTICAL SIGNIFICANCE; ANIMAL; MALE; METHODOLOGY; PATHOLOGY; SYNOVIUM; VASCULARIZATION;

ANIMALS; ARTHRITIS; CONTRAST MEDIA; MAGNETIC RESONANCE IMAGING; MALE; MICROCIRCULATION; RABBITS; SYNOVIAL MEMBRANE;

EID: 33646910611     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.04.1138     Document Type: Article

References (41)

1. Harris ED Jr. Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 1990; 322:1277-1289
2. Szekanecz Z, Szegedi G, Koch AE. Angiogenesis in rheumatoid arthritis: pathogenic and clinical significance. J Invest Med 1998; 46:27-41
3. Kalden-Nemeth D, Grebmeier J, Antoni C, Manger B, Wolf F, Kalden JR. NMR monitoring of rheumatoid arthritis patients receiving anti-TNF-α monoclonal antibody therapy. Rheumatol Int 1997; 16:249-255
4. Neeman M, Provenzale JM, Dewhirst MW. Magnetic resonance imaging applications in the evaluation of tumor angiogenesis. Semin Radiat Oncol 2001; 11:70-82
5. Bhujwalla ZM, Artemov D, Glockner J. Tumor angiogenesis, vascularization, and contrast-enhanced magnetic resonance imaging. Top Magn Reson Imaging 1999; 10:92-103
6. Taylor JS, Tofts PS, Port R, et al. MR imaging of tumor microcirculation: promise for the new millennium. J Magn Reson Imaging 1999; 10:903-907
7. Yuh WT. An exciting and challenging role for the advanced contrast MR imaging. J Magn Reson Imaging 1999; 10:221-222
8. Jason HE. Chronic arthritis in rabbits. Methods Enzymol 1988; 162:379-385
9. Cooke TDV. Antigen-induced arthritis, polyarthritis, and tenosynovitis. In: Greenwald RA, Diamond HS, eds. CRC handbook of animal models for rheumatoid diseases, vol. 1. Boca Raton, FL: CRC Press, 1988:53-79
10. Mayr NA, Hawighorst H, Yuh WT, Essig M, Magnotta VA, Knopp MV. MR microcirculation assessment in cervical cancer: correlations with histomorphological tumor markers and clinical outcome. J Magn Reson Imaging 1999; 10:267-276
11. Noseworthy MD, Stanisz GJ, Kim JK, Stainsby JA, Wright GA. Tracking oxygen effects on MR signal in blood and skeletal muscle during hyperoxia exposure. J Magn Reson Imaging 1999; 9:814-820
12. Choyke PL, Dwyer AJ, Knopp MV. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 2003; 17:509-520
13. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997; 7:91-101
14. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusible tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10:223-232
15. Noseworthy M, Bray TM. Zinc deficiency exacerbates loss in blood-brain barrier integrity induced by hyperoxia measured by dynamic MRI. Proc Soc Exp Biol Med 2000; 223:175-182
16. McDonald TL, Weber A, Smith JW. A monoclonal antibody sandwich immunoassay for serum amyloid A (SAA) protein. J Immunol Methods 1991; 144:149-155
17. Oehler S, Neureiter D, Meyer-Scholten C, Aigner T. Subtyping of osteoarthritic synoviopathy. Clin Exp Rheumatol 2002; 20:633-640
18. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the area under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44:837-845
19. Dvorak AM, Kohn S, Morgan ES, et al. The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. J Leukoc Biol 1996; 59:100-115
20. Noseworthy MD, Ackerley C, Qi X, Wright GA. Correlating subcellular contrast agent location from dynamic contrast enhanced magnetic resonance imaging (dMRI) and analytical electron microscopy. Acad Radiol 2002; 9[suppl]:S514-S518
21. Ackerley CA, Noseworthy MD, Tilups A, Wright GA, Becker LE. Detection and localization of Gd-DTPA following dynamic contrast enhanced magnetic resonance imaging (dMRI) using cryo field emission electron microscopy (FESEM) and energy dispersive X-ray spectrometry (EDS). Microsc Microanal 2002; 8:456-457
22. Knopp MV, Giesel FL, Marcos H, et al. Dynamic contrast-enhanced magnetic resonance imaging in oncology. Top Magn Reson Imaging 2001; 12:301-308
23. Padhani AR, Gapinski CJ, Macvicar DA, et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 2000; 55:99-109
24. Levick JR. Hypoxia and acidosis in chronic inflammatory arthritis: relation to vascular supply and dynamic effusion pressure. J Rheumatol 1990; 17:579-582
25. Ogan MD, Schmiedl U, Moseley ME, Grodd W, Paajanen H, Brasch RC. Albumin labeled with Gd-DTPA: an intravascular contrast-enhancing agent for magnetic resonance blood pool imaging - preparation and characterization. Invest Radiol 1987; 22:665-671
26. Hunneyball IM, Spowage M, Crossley MJ, Rowe IF, Baltz ML. Acute phase protein changes in antigen-induced mono-articular arthritis in rabbits and mice. Clin Exp Immunol 1986; 65:311-318
27. Jain RK. Determinants of tumor blood flow: a review. Cancer Res 1988; 48:2641-2658
28. Tamai K, Yamato M, Yamaguchi T, Ohno W. Dynamic magnetic resonance imaging for the evaluation of synovitis in patients with rheumatoid arthritis. Arthritis Rheum 1994; 37:1151-1157
29. Gaffney K, Cookson J, Blake D, Coumbe A, Blades S. Quantification of rheumatoid synovitis by magnetic resonance. Arthritis Rheum 1995; 38:1610-1617
30. Hawighorst H, Weikel W, Knapstein PG, et al. Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. Clin Cancer Res 1998; 4:2305-2312
31. Tynninen O, Aronen HJ, Ruhala M, et al. MRI enhancement and microvascular density in gliomas: correlation with tumor cell proliferation. Invest Radiol 1999; 34:427-434
32. Buade L, Murakami J, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 1996; 200:639-649
33. Hulka CA, Edmister WB, Smith BL, et al. Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis. Radiology 1997; 205:837-842
34. Daldrup H, Shames DM, Wendland M, et al. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. AJR 1998; 171:941-949
35. Postema S, Pattynama P, van Rijswijk C, et al. Cervical carcinoma: can dynamic contrast-enhanced MR imaging help predict tumor aggressiveness? Radiology 1999; 210:217-220
36. Knopp MV, Weiss E, Sinn HP, et al. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 1999; 10:260-266
37. Brasch RC, Li KC, Husband JE, et al. In vivo monitoring of tumor angiogenesis with MR imaging. Acad Radiol 2000; 7:812-823
38. Ceponis A, Waris E, Monkkonen J, et al. Effects of low-dose, noncytotoxic, intraarticular liposomal clodronate on development of erosions and proteoglycan loss in established antigen-induced arthritis in rabbits. Arthritis Rheum 2001; 44:1908-1916
39. Storgard CM, Stupack DG, Jonczyk A, Goodman SL, Fox RI, Cheresh DA. Decreased angiogenesis and arthritic disease in rabbits treated with an alpha-v-beta-3-antagonist. J Clin Invest 1999; 103:47-54
40. Washburn LR, Cole BC, Gelman MI, Ward JR. Chronic arthritis of rabbits induced by mycoplasmas: clinical, microbiologic, and histologic features. Arthritis Rheum 1980; 23:825-836
41. Hayes C, Padhani AR, Leach MO. Assessing changes in tumor vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed 2002; 15:154-163